The Patent Finder

Compositions and Methods for Epigenetic Regulation of HBV Gene Expression

Nchroma Bio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2024/029529, filed May 15, 2024. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,390,538Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
In force
 · Medium confidence
Nchroma Bio, Inc.In force
Medium confidence
US 12,558,437Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
In force
 · Medium confidence
Nchroma Bio, Inc.In force
Medium confidence
US 12,649,003Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
In force
 · Low confidence
Nchroma Bio, Inc.In force
Low confidence
Application 19/390,246Compositions and Methods for Epigenetic Regulation of HBV Gene Expression
Pending
Not granted
nChroma Bio, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Nchroma Bio, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited